FDA May Take Action Against Johnson & Johnson

The New York Times (5/28, B1, Singer) reports that McNeil Consumer Healthcare, the division of Johnson & Johnson that recalled millions of bottles of liquid children’s Tylenol, “may face criminal penalties, product seizures, or other sanctions, an official from the Food and Drug Administration said Thursday.” At a Congressional hearing yesterday, the principal deputy commissioner at the FDA, Joshua Sharfstein, said that the agency found “a pattern of violations in manufacturing and quality control practices” that “led to a number of recent recalls.”

Following revelations at the hearing that McNeil hired contractors to buy the products under orders not to mention the word ‘recall,’ the chairwomen of Johnson & Johnson’s consumer division, Colleen Goggins, apologized “to the mothers and fathers and caregivers for the concern and inconvenience” caused by the recall. Los Angeles Times (5/28, Zajac)